{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:54:57Z","timestamp":1791273297428,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T00:00:00Z","timestamp":1434672000000},"content-version":"vor","delay-in-days":444,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.cell.2014.01.066","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T12:15:21Z","timestamp":1397132121000},"page":"382-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":435,"title":["Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor \u03b2 Signaling"],"prefix":"10.1016","volume":"157","author":[{"given":"Susann","family":"Weissmueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eusebio","family":"Manchado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Saborowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"John\u00a0P.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvin","family":"Wagenblast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie\u00a0A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hwan","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil\u00a0T.","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darjus\u00a0F.","family":"Tschaharganeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kitzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Aust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke\u00a0K.","family":"Markert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean\u00a0M.","family":"Grimmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pilarsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Prives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew\u00a0V.","family":"Biankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott\u00a0W.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2014.01.066_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cell.2009.01.039","article-title":"A mutant-p53\/Smad complex opposes p63 to empower TGFbeta-induced metastasis","volume":"137","author":"Adorno","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.cell.2014.01.066_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/bbrc.1995.1642","article-title":"Isolation and characterization of the mouse PDGF beta-receptor promoter","volume":"210","author":"Ballagi","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cell.2014.01.066_bib3","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1101\/gad.1795709","article-title":"A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint","volume":"23","author":"Beckerman","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2014.01.066_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ccr.2004.08.034","article-title":"PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis","volume":"6","author":"Cao","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2014.01.066_bib5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/13543776.2010.493559","article-title":"Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature","volume":"20","author":"Dai","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.cell.2014.01.066_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ccr.2006.08.013","article-title":"Gain of function of mutant p53: the mutant p53\/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation","volume":"10","author":"Di Agostino","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2014.01.066_bib7","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1038\/onc.2012.334","article-title":"Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis","volume":"32","author":"Dong","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2014.01.066_bib8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1101\/gad.190678.112","article-title":"Mutant p53: one name, many proteins","volume":"26","author":"Freed-Pastor","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2014.01.066_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cell.2011.12.017","article-title":"Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway","volume":"148","author":"Freed-Pastor","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cell.2014.01.066_bib10","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/MCB.21.5.1874-1887.2001","article-title":"A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain","volume":"21","author":"Gaiddon","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cell.2014.01.066_bib11","doi-asserted-by":"crossref","first-page":"e67581","DOI":"10.1371\/journal.pone.0067581","article-title":"MiR-34a\/c-dependent PDGFR-\u03b1\/\u03b2 downregulation inhibits tumorigenesis and enhances TRAIL-induced apoptosis in lung cancer","volume":"8","author":"Garofalo","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cell.2014.01.066_bib12","doi-asserted-by":"crossref","first-page":"42242","DOI":"10.1074\/jbc.M508690200","article-title":"Galpha12\/13 is essential for directed cell migration and localized Rho-Dia1 function","volume":"280","author":"Goulimari","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2014.01.066_bib13","doi-asserted-by":"crossref","first-page":"39769","DOI":"10.1074\/jbc.M204483200","article-title":"p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y","volume":"277","author":"Hackzell","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2014.01.066_bib14","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/cdd.2013.17","article-title":"Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis","volume":"20","author":"Hanel","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2014.01.066_bib15","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2014.01.066_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2014.01.066_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2014.01.066_bib18","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/bjc.2013.409","article-title":"Phase I\/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205","volume":"109","author":"Hoehler","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cell.2014.01.066_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1432-1033.1997.t01-2-00142.x","article-title":"Nuclear factor Y controls the basal transcription activity of the mouse platelet-derived-growth-factor beta-receptor gene","volume":"246","author":"Ishisaki","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.cell.2014.01.066_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(06)97001-8","article-title":"Structural biology of the tumor suppressor p53 and cancer-associated mutants","volume":"97","author":"Joerger","year":"2007","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.cell.2014.01.066_bib21","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cell.2014.01.066_bib22","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1101\/gad.424807","article-title":"Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion","volume":"21","author":"Kitzing","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2014.01.066_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2004.11.006","article-title":"Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome","volume":"119","author":"Lang","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.cell.2014.01.066_bib24","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1200\/JCO.2012.44.0412","article-title":"Targeting mutant p53 in human tumors","volume":"30","author":"Lehmann","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.cell.2014.01.066_bib25","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/1097-0142(19950315)75:6<1327::AID-CNCR2820750615>3.0.CO;2-P","article-title":"Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma","volume":"75","author":"Levesque","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.cell.2014.01.066_bib26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: growing ever more complex","volume":"9","author":"Levine","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2014.01.066_bib27","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1200\/JCO.2009.21.8487","article-title":"Phase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor in patients with advanced cancers","volume":"27","author":"Lewis","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.cell.2014.01.066_bib28","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/sj.onc.1210311","article-title":"Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?","volume":"26","author":"Li","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2014.01.066_bib29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(04)15841-8","article-title":"Pancreatic cancer","volume":"363","author":"Li","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2014.01.066_bib30","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1128\/MCB.05574-11","article-title":"TopBP1 mediates mutant p53 gain of function through NF-Y and p63\/p73","volume":"31","author":"Liu","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cell.2014.01.066_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2407-13-95","article-title":"3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing","volume":"13","author":"Longati","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cell.2014.01.066_bib32","article-title":"Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells","author":"Masciarelli","year":"2013","journal-title":"Oncogene"},{"issue":"Database issue","key":"10.1016\/j.cell.2014.01.066_bib33","doi-asserted-by":"crossref","first-page":"D108","DOI":"10.1093\/nar\/gkj143","article-title":"TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes","volume":"34","author":"Matys","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2014.01.066_bib34","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1038\/sj.onc.1210120","article-title":"Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion","volume":"26","author":"Mehta","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2014.01.066_bib35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.mam.2013.01.002","article-title":"Mammalian iron transporters: families SLC11 and SLC40","volume":"34","author":"Montalbetti","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.cell.2014.01.066_bib36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1073\/pnas.0908428107","article-title":"Mutant p53 drives metastasis and overcomes growth arrest\/senescence in pancreatic cancer","volume":"107","author":"Morton","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2014.01.066_bib37","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2009.11.026","article-title":"Mutant p53 drives invasion by promoting integrin recycling","volume":"139","author":"Muller","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.cell.2014.01.066_bib38","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1038\/onc.2012.305","article-title":"Mutant p53 drives invasion in breast tumors through up-regulation of miR-155","volume":"32","author":"Neilsen","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2014.01.066_bib39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","article-title":"Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome","volume":"119","author":"Olive","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.cell.2014.01.066_bib58","article-title":"Mutant p53 gain-of-function in cancer","volume":"2","author":"Oren","year":"2010","journal-title":"Cold\u00a0Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.cell.2014.01.066_bib40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1535-6108(03)00089-8","article-title":"PDGF receptors as cancer drug targets","volume":"3","author":"Pietras","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2014.01.066_bib41","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.1200\/JCO.2005.00.471","article-title":"The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment","volume":"23","author":"Russo","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.cell.2014.01.066_bib42","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1093\/nar\/26.16.3800","article-title":"Conservation and divergence of NF-Y transcriptional activation function","volume":"26","author":"Serra","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2014.01.066_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35106009","article-title":"Assessing TP53 status in human tumours to evaluate clinical outcome","volume":"1","author":"Soussi","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2014.01.066_bib44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1593\/neo.121726","article-title":"PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells","volume":"15","author":"Steller","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.cell.2014.01.066_bib45","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nature09459","article-title":"TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs","volume":"467","author":"Su","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cell.2014.01.066_bib46","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1182\/blood-2002-10-3059","article-title":"The CNS is a sanctuary for leukemic cells in mice receiving imatinib mesylate for Bcr\/Abl-induced leukemia","volume":"101","author":"Wolff","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cell.2014.01.066_bib47","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis for sequence count data","volume":"11","author":"Anders","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.cell.2014.01.066_bib48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cell.2014.01.066_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature11233","article-title":"Landscape of transcription in human cells","volume":"489","author":"Djebali","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cell.2014.01.066_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cell.2014.01.066_bib51","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ng1091","article-title":"An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in\u00a0vivo","volume":"33","author":"Hemann","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2014.01.066_bib52","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1101\/gad.943001","article-title":"Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras","volume":"15","author":"Jackson","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2014.01.066_bib53","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1093\/nar\/gkp596","article-title":"Transcriptome analysis by strand-specific sequencing of complementary DNA","volume":"37","author":"Parkhomchuk","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2014.01.066_bib54","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2009.11.005","article-title":"Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer","volume":"138","author":"Smith","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2014.01.066_bib55","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2014.01.066_bib56","doi-asserted-by":"crossref","first-page":"e31507","DOI":"10.1371\/journal.pone.0031507","article-title":"DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cell.2014.01.066_bib57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nbt.1720","article-title":"Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi","volume":"29","author":"Zuber","year":"2011","journal-title":"Nat. Biotechnol."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867414002141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867414002141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T22:58:10Z","timestamp":1538693890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867414002141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0092867414002141"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2014.01.066","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718348656.793494314","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718348656.793494188","asserted-by":"object"}]},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor \u03b2 Signaling","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2014.01.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}